These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. Sriskandan S, Faulkner L, Hopkins P. Int J Biochem Cell Biol; 2007 Apr; 39(1):12-9. PubMed ID: 17029999 [Abstract] [Full Text] [Related]
14. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles. Norrby-Teglund A, Nepom GT, Kotb M. Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341 [Abstract] [Full Text] [Related]
15. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients. Norrby-Teglund A, Low DE, McGeer A, Kotb M. Adv Exp Med Biol; 1997 Sep; 418():563-6. PubMed ID: 9331714 [No Abstract] [Full Text] [Related]
16. Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model. Tarnutzer A, Andreoni F, Keller N, Zürcher C, Norrby-Teglund A, Schüpbach RA, Zinkernagel AS. Clin Microbiol Infect; 2019 Apr; 25(4):512.e7-512.e13. PubMed ID: 30025835 [Abstract] [Full Text] [Related]
19. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections. Müller-Alouf H, Geoffroy C, Geslin P, Bouvet A, Felten A, Günther E, Ozegowski JH, Alouf JE. Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388 [Abstract] [Full Text] [Related]